Pharma Through

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

PatentsUSA

Lupin Resolves U.S. Patent Litigation with Astellas Pharma Through $90 Million Settlement

Lupin Ltd., a leading Indian pharmaceutical firm, has reached a $90 million settlement with Japan-based Astellas Pharma Inc. to resolve ongoing patent disputes concerning the U.S. rights to mirabegron, a drug used to treat overactive bladder. The agreement allows Lupin to continue marketing its generic version in the…

Thursday, May 14, 2026

Newsletters & Digests

Follow Pharma Through

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All newsroom coverage Filtered archive